Anthony C. Hayes Esq.
Net Worth

Last updated:

What is Anthony C. Hayes Esq. net worth?

The estimated net worth of Mr. Anthony C. Hayes Esq. is at least $12,100,000 as of 20 Sep 2023. He has received compensation worth at least $12,100,000 in AIkido Pharma Inc..

What is the salary of Anthony C. Hayes Esq.?

Mr. Anthony C. Hayes Esq. salary is $1,100,000 per year as Chief Executive Officer, Principal Financial Officer, Principal Accounting Officer & Director in AIkido Pharma Inc..

How old is Anthony C. Hayes Esq.?

Mr. Anthony C. Hayes Esq. is 57 years old, born in 1968.

What stocks does Anthony C. Hayes Esq. currently own?

As insider, Mr. Anthony C. Hayes Esq. owns shares in one company:

Company Title Shares Price per share Total value
AIkido Pharma Inc. (AIKI) Chief Executive Officer, Principal Financial Officer, Principal Accounting Officer & Director 9,500 $0 $0

What does AIkido Pharma Inc. do?

AIkido Pharma Inc., a biotechnology company, focuses on developing small-molecule anti-cancer therapeutics. The company's pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small molecule treatment for acute myeloid leukemia and acute lymphoblastic leukemia. The company is also developing an antiviral platform that inhibits replication of viruses, including influenza virus, Ebolavirus and Marburg virus, SARS-CoV, MERS-CoV, and SARS-CoV-2. It has license agreements with the University of Texas, University of Maryland Baltimore, Silo Pharma Inc., and Wake Forest University Health Sciences. The company was formerly known as Spherix Incorporated and changed its name to AIkido Pharma Inc. in March 2021. AIkido Pharma Inc. was founded in 1967 and is headquartered in New York, New York.

AIKI logo
AIKI
AIkido Pharma Inc.

Anthony C. Hayes Esq. insider trading

AIkido Pharma Inc.

Transaction Date Security Shares Price per share Total value Source
Purchase
Common Stock 2,500 $2.58 $6,438
Purchase
Common Stock 5,000 $2.74 $13,715
Purchase
Common Stock 7,500 $2.5 $18,750
Purchase
Common Stock 2,000 $2.75 $5,494
Purchase
Common Stock 2,000 $2.86 $5,718
Purchase
Common Stock 2,000 $2.94 $5,880
Purchase
Common Stock 1,319 $2.88 $3,792
Purchase
Common Stock 506 $2.89 $1,460
Purchase
Common Stock 2,000 $2.75 $5,500
Purchase
Common Stock 2,000 $2.77 $5,538
Purchase
Common Stock 2,000 $2.77 $5,534
Purchase
Common Stock 30,000 $3.44 $103,140
Purchase
Common Stock 4,500 $3.69 $16,605
Purchase
Common Stock 5,000 $3.7 $18,485
Purchase
Common Stock 5,000 $3.63 $18,125
Purchase
Common Stock 5,000 $3.68 $18,415
Purchase
Common Stock 5,000 $3.56 $17,810
Purchase
Common Stock 5,000 $3.48 $17,380
Purchase
Common Stock 24,957 $6.32 $157,803
Purchase
Common Stock 38,208 $6.33 $241,666
Purchase
Common Stock 10,000 $0.99 $9,900
Purchase
Common Stock 10,000 $0.99 $9,900
Purchase
Common Stock 10,000 $0.93 $9,300
Purchase
Common Stock, $.0001 par value per share 10,000 $0.44 $4,400
Purchase
Common Stock, $.0001 par value per share 1,000 $1 $999
Purchase
Common Stock, $.0001 par value per share 1,000 $1.04 $1,040
Purchase
Common Stock, $.0001 par value per share 2,000 $0.97 $1,940
Purchase
Common Stock, $.0001 par value per share 2,000 N/A N/A
Purchase
Common Stock 2,500 $1.69 $4,225
Purchase
Common Stock 4,000 N/A N/A

AIkido Pharma key executives

AIkido Pharma Inc. executives and other stock owners filed with the SEC: